Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection
Yo Sasaki(SHOWA Medical University), Jeffrey Milbrandt(James S. McDonnell Foundation), Weixi Gu(The University of Queensland), Yun Shi(Griffith University), Boštjan Kobe(The University of Queensland), Thomas Ve(Griffith University), Jian Zhu(Washington University in St. Louis), Aaron DiAntonio(Washington University in St. Louis)
Cited by 37
Related Papers
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
|Science|2004|1.1k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899